|
Age (median, Q1-Q3)
|
39
|
(32–46)
|
42
|
(36–48)
|
42
|
(34–47)
|
U = 24,555.000
|
0.008
|
|
Heterosexual: n (%)
|
127
|
(88.8)
|
251
|
(84.5)
|
378
|
(85.9)
| |
0.245
|
|
Completed high school: n (%)
|
67
|
(46.9)
|
126
|
(42.4)
|
193
|
(43.9)
| |
0.412
|
|
Unemployed: n (%)
|
111
|
(77.6)
|
214
|
(72.1)
|
325
|
(73.9)
| |
0.247
|
|
Living condition: n (%)
|
|
Living in a dormitory (rehabilitation center)
|
117
|
(81.8)
|
222
|
(74.7)
|
339
|
(77.0)
| |
0.116
|
|
Daycare
|
11
|
(7.7)
|
30
|
(10.1)
|
41
|
(9.3)
| |
0.486
|
|
Undergoing training as rehabilitation staff
|
15
|
(10.5)
|
45
|
(15.2)
|
60
|
(13.6)
| |
0.235
|
|
Chronic disease (physical disease): n (%)
|
22
|
(15.4)
|
74
|
(25.2)
|
96
|
(22.0)
| |
0.026
|
|
Primary drug: n (%)
|
|
Methamphetamine
|
56
|
(39.2)
|
214
|
(72.1)
|
270
|
(61.4)
| |
< 0.001
|
|
NPS
|
22
|
(15.4)
|
38
|
(12.8)
|
60
|
(13.6)
| |
0.461
|
|
Organic solvent
|
14
|
(9.8)
|
12
|
(4.0)
|
26
|
(5.9)
| |
0.029
|
|
Marijuana
|
11
|
(7.7)
|
13
|
(4.4)
|
24
|
(5.5)
| |
0.179
|
|
Prescription drugs
|
17
|
(11.9)
|
7
|
(2.4)
|
24
|
(5.5)
| |
< 0.001
|
|
Over-the-counter drugs
|
14
|
(9.8)
|
6
|
(2.0)
|
20
|
(4.5)
| |
0.001
|
|
Others (cocaine, heroin, MDMA, gas)
|
9
|
(6.3)
|
7
|
(2.4)
|
16
|
(3.6)
| |
0.055
|
|
Drug-related criminal history: n (%)
|
40
|
(28.0)
|
163
|
(54.9)
|
203
|
(46.1)
| |
< 0.001
|
|
Never experienced treatment: n (%)
|
22
|
(15.5)
|
64
|
(21.8)
|
86
|
(19.7)
| |
0.157
|
|
Consistent condom use under the influence of drugs: n (%)
|
|
Always uses condoms
|
66
|
(46.2)
|
38
|
(12.8)
|
104
|
(23.7)
| |
< 0.001
|
|
Sometimes a non-condom user
|
27
|
(18.9)
|
50
|
(16.9)
|
77
|
(17.5)
| |
0.595
|
|
Mostly a non-condom user
|
50
|
(35.0)
|
208
|
(70.3)
|
258
|
(58.8)
| |
< 0.001
|
|
Injecting and sharing needles during drug use: n (%)
|
|
None
|
74
|
(52.9)
|
60
|
(20.5)
|
134
|
(31.0)
| |
< 0.001
|
|
Only experienced injection
|
16
|
(11.4)
|
46
|
(15.8)
|
62
|
(14.4)
| |
0.245
|
|
Experienced injection and sharing needles
|
50
|
(35.7)
|
186
|
(63.7)
|
236
|
(54.6)
| |
< 0.001
|
|
Diagnosis of sexually transmitted disease in lifetime: n (%)
|
|
Hepatitis A
|
0
|
(0.0)
|
1
|
(0.3)
|
1
|
(0.2)
| |
1.000
|
|
Hepatitis B
|
1
|
(0.7)
|
18
|
(6.3)
|
19
|
(4.5)
| |
0.006
|
|
Hepatitis C
|
19
|
(13.6)
|
92
|
(32.2)
|
111
|
(26.1)
| |
< 0.001
|
|
Gonorrhea
|
6
|
(4.3)
|
30
|
(10.5)
|
36
|
(8.5)
| |
0.040
|
|
Chlamydia
|
7
|
(5.0)
|
22
|
(7.7)
|
29
|
(6.8)
| |
0.413
|
|
Syphilis
|
2
|
(1.4)
|
19
|
(6.6)
|
21
|
(4.9)
| |
0.017
|
|
HIV
|
0
|
(0.0)
|
18
|
(6.3)
|
18
|
(4.2)
| |
0.001
|
|
Never diagnosis of STD
|
110
|
(78.6)
|
139
|
(48.6)
|
249
|
(58.5)
| |
< 0.001
|
|
DAST-20 total score (median, Q1-Q3)
|
13.0
|
(10–16)
|
15.0
|
(12–17)
|
14.0
|
(12–16)
|
U = 25,873.500
|
< 0.001
|
